15 results · 21ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

ANGIOJET DVX RHEOLYTIC THROMBECTOMY CATHETER

FDA 510(k)
FDA Class 2 ·Cardiovascular

NIM-ECLIPSE® CONTROLLER

FDA Adverse Event
Injury ·MEDTRONIC XOMED, INC·Product code GWF·December 9, 2014

AXON ECLIPSE CONTROLLER

FDA Adverse Event
Malfunction ·MEDTRONIC XOMED, INC.·Product code GWF·November 27, 2013

BRIDGE III RECEIVER

FDA 510(k)
FDA Class 2 ·Cardiovascular

MODIFICATION TO MARSPO2, MODEL 2001

FDA 510(k)
FDA Class 2 ·Cardiovascular

NIM-ECLIPSE® ELECTRODE

FDA Adverse Event
Injury ·MEDTRONIC XOMED, INC.·Product code GXZ·May 16, 2016

NIM-ECLIPSE® ELECTRODE

FDA Adverse Event
Injury ·MEDTRONIC XOMED INC.·Product code GXZ·May 6, 2016

ONETOUCHPING GLUCOSEMGMTSYSTEM

FDA Adverse Event
Injury ·ANIMAS CORPORATION·Product code LZG·April 10, 2013

LAP-BAND AP ADJUSTABLE GASTRIC BANDING SYSTEM (STANDARD)

FDA Adverse Event
Injury ·ALLERGAN·Product code LTI·April 1, 2011

RIATA ST ACTIVE FIXATION LEAD

FDA Adverse Event
Injury ·ST JUDE MEDICAL CARDIAC RHYTHM MANAGEMENT DIVISION·Product code LWS·May 27, 2008

DIGITAL PREAMPLIFIER

FDA Adverse Event
Malfunction ·MEDTRONIC (CHANGZHOU) MEDICAL DEVICES·Product code GWF·May 9, 2026

Stryker End Cap, Standard T2 Humerus ¿6 mm Catalog Number: 18300003S - Product Usage: Stryker implants are single use devices intended for the temporary fixation, correction or stabilization of bones.

FDA Enforcement
Class II ·Terminated·Stryker GmbH·June 24, 2020

CONTROLLER ECLC ECLIPSE

FDA Adverse Event
Malfunction ·MEDTRONIC XOMED INC.·Product code GWF·May 23, 2014

IPC® HANDPIECE - STYLUS TOUCH®

FDA Adverse Event
Malfunction ·MEDTRONIC XOMED INC.·Product code HBE·December 11, 2019

cobas 6000 Modular Series system; Part Numbers: 1. 04745914001 cobas c 501 module; 2. 05036453001 cobas 6000 UL c 501 + Core Fix configuration; 3. 05036453692 - cobas 6000 UL + CORE CU; and 4. 05860636001 cobas 6000 c 501 (UL) V

FDA Enforcement
Class II ·Terminated·Roche Diagnostics Corporation·March 14, 2018